Characterization of impurities and degradants using mass spectrometry /

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: Wiley InterScience (Online service)
Άλλοι συγγραφείς: Pramanik, Birendra N., 1944-, Lee, Mike S., 1960-, Chen, Guodong
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Hoboken, N.J. : John Wiley, [2011]
Σειρά:Wiley series on pharmaceutical science and biotechnology.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 05152nam a2200853 4500
001 ocn746326254
003 OCoLC
005 20170124072011.4
006 m o d
007 cr cn|||||||||
008 110811s2011 njua ob 001 0 eng d
010 |z  2010023283 
040 |a DG1  |b eng  |e pn  |c DG1  |d CDX  |d YDXCP  |d N$T  |d E7B  |d OCLCQ  |d EBLCP  |d OCLCO  |d OCLCQ  |d OCLCF  |d OCLCA  |d OCLCQ  |d IDEBK  |d OCLCQ  |d MHW  |d UKDOC  |d NLGGC  |d OCLCQ  |d COO  |d OCLCQ  |d DEBBG  |d AZK  |d GrThAP 
019 |a 748534035  |a 756501436  |a 770866893  |a 961512949  |a 962579040 
020 |a 9780470921371  |q (electronic bk.) 
020 |a 0470921374  |q (electronic bk.) 
020 |a 9780470921364  |q (electronic bk.) 
020 |a 0470921366  |q (electronic bk.) 
020 |z 9780470386187 
020 |z 0470386185 
020 |z 9780470922972 
020 |z 0470922974 
029 1 |a AU@  |b 000047980921 
029 1 |a DKDLA  |b 820120-katalog:000573118 
029 1 |a NZ1  |b 15915585 
029 1 |a DEBBG  |b BV043393405 
035 |a (OCoLC)746326254  |z (OCoLC)748534035  |z (OCoLC)756501436  |z (OCoLC)770866893  |z (OCoLC)961512949  |z (OCoLC)962579040 
037 |a 10.1002/9780470921371  |b Wiley InterScience  |n http://www3.interscience.wiley.com 
050 4 |a RS189.5.S65  |b C53 2011 
060 4 |a 2011 G-724 
060 4 |a QV 25 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
082 0 4 |a 615/.1  |2 22 
049 |a MAIN 
245 0 0 |a Characterization of impurities and degradants using mass spectrometry /  |c edited by Birendra N. Pramanik, Mike S. Lee, Guodong Chen. 
264 1 |a Hoboken, N.J. :  |b John Wiley,  |c [2011] 
264 4 |c ©2011 
300 |a 1 online resource (xxii, 462 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
380 |a Bibliography 
490 1 |a Wiley series on pharmaceutical science and biotechnology 
505 0 |a Frontmatter -- Methodology. Introduction to Mass Spectrometry / Scott A Smith, Ruth Waddell Smith, Yu Xia, Zheng Ouyang -- LC Method Development and Strategies / Gang Xue, Yining Zhao -- Rapid Analysis of Drug-Related Substances Using Desorption Electrospray Ionization and Direct Analysis in Real Time Ionization Mass Spectrometry / Hao Chen, Jiwen Li -- Orbitrap High-Resolution Applications / Robert J Strife -- Structural Characterization of Impurities and Degradation Products in Pharmaceuticals Using High-Resolution LC-MS and Online Hydrogen/Deuterium Exchange Mass Spectrometry / Guodong Chen, Birendra N Pramanik -- Isotope Patten Recognition on Molecular Formula Determination for Structural Identification of Impurities / Ming Gu -- Application. Practical Application of Very High-Pressure Liquid Chromatography across the Pharmaceutical Development₆Manufacturing Continuum / Brent Kleintop, Qinggang Wang -- Impurity Identification for Drug Substances / David W Berberich, Tao Jiang, Joseph McClurg, Frank Moser, R Randy Wilhelm -- Impurity Identification in Process Chemistry by Mass Spectrometry / David Q Liu, Mingjiang Sun, Lianming Wu -- Structure Elucidation of Pharmaceutical Impurities and Degradants in Drug Formulation Development / Changkang Pan, Frances Liu, Michael Motto -- Investigation of Degradation Products and Extractables in Developing Topical OTC (Over the Counter) and NCE (New Chemical Entity) Consumer Healthcare Medication Products / Fa Zhang -- Characterization of Impurities and Degradants in Protein Therapeutics by Mass Spectrometry / Li Tao, Michael Ackerman, Wei Wu, Peiran Liu, Reb Russell -- Identification and Quantification of Degradants and Impurities in Antibodies / David M Hambly, Himanshu S Gadgil -- Index. 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
650 0 |a Drugs  |x Analysis. 
650 0 |a Drugs  |x Spectra. 
650 0 |a Mass spectrometry. 
650 0 |a Contamination (Technology) 
650 2 |a Mass Spectrometry  |x methods. 
650 2 |a Pharmaceutical Preparations  |x analysis. 
650 2 |a Drug Contamination. 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a Contamination (Technology)  |2 fast  |0 (OCoLC)fst00876602 
650 7 |a Drugs  |x Analysis.  |2 fast  |0 (OCoLC)fst00898769 
650 7 |a Drugs  |x Spectra.  |2 fast  |0 (OCoLC)fst00898921 
650 7 |a Mass spectrometry.  |2 fast  |0 (OCoLC)fst01011435 
655 4 |a Electronic books. 
700 1 |a Pramanik, Birendra N.,  |d 1944- 
700 1 |a Lee, Mike S.,  |d 1960- 
700 1 |a Chen, Guodong. 
710 2 |a Wiley InterScience (Online service) 
776 0 8 |i Print version:  |t Characterization of impurities and degradants using mass spectrometry.  |d Hoboken, N.J. : John Wiley, ©2011  |z 9780470386187  |w (DLC) 2010023283  |w (OCoLC)430842666 
830 0 |a Wiley series on pharmaceutical science and biotechnology. 
856 4 0 |u https://doi.org/10.1002/9780470921371  |z Full Text via HEAL-Link 
994 |a 92  |b DG1